Related Experiment Video
Updated: Apr 19, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
ErbB4 as a potential molecular target in the treatment of esophageal squamous cell cancers
Ke Zhao1, Bao-Jun Chen1, Zhi-Guo Chen1
1Department of Thoracic Surgery, The Central Hospital of Wuhan, Jiang'an District, Wuhan, Hubei 430014, China.
Abstract:
ErbB4 is an important member of ErbB subfamily of tyrosine kinases receptor with overexpression in several tumors; however its biological role in esophageal cancer is poorly understood till date. The main objective of this study was to examine whether miRNA-140-5p could target and control ErbB4 expression at transcriptional level. The ErbB4 expressions in different cell lines were evaluated by western blotting and luciferase assay. Moreover, cell proliferation, apoptosis, and cell invasion studies were investigated using MTT, flow cytometry, and transwell assays. miRNA-140-5p remarkably downregulated the ErbB4 expression in EC9706 and TE-1A cell lines. Furthermore, miRNA-140-5p transfected cell significantly controlled the cell proliferation and enhanced the apoptosis of multiple cells. Additionally, miRNA-140-5p had marked effect on the DNA synthesis and caspase 3/7 activity in comparison to control cells. Specifically, miRNA-140-5p inhibited/repressed the cancer cell invasion and migration in a sign to have important biological role in esophageal carcinomas. Taken together, miRNA-140-5p could act as a potential molecular target in ErbB4 overexpressing ESCC cell lines paving the way for effective esophageal cancer treatment.
Insights
MicroRNA-140-5p effectively targets ErbB4, a receptor tyrosine kinase, in esophageal cancer cells. This finding suggests miRNA-140-5p as a potential therapeutic target for esophageal squamous cell carcinoma (ESCC).
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- ErbB4, a receptor tyrosine kinase, is overexpressed in various cancers, but its role in esophageal cancer remains unclear.
- Understanding the regulation of ErbB4 is crucial for developing targeted therapies for esophageal cancer.
Purpose of the Study:
- To investigate if microRNA-140-5p (miRNA-140-5p) can target and regulate ErbB4 expression at the transcriptional level.
- To evaluate the biological effects of miRNA-140-5p on esophageal cancer cell behavior.
Main Methods:
- Western blotting and luciferase assays were used to assess ErbB4 expression.
- Cell proliferation, apoptosis, and invasion were studied using MTT, flow cytometry, and transwell assays.
Main Results:
- miRNA-140-5p significantly downregulated ErbB4 expression in EC9706 and TE-1A esophageal cancer cell lines.
- Transfection with miRNA-140-5p suppressed cell proliferation, enhanced apoptosis, and reduced DNA synthesis and caspase 3/7 activity.
- miRNA-140-5p markedly inhibited cancer cell invasion and migration.
Conclusions:
- miRNA-140-5p acts as a regulator of ErbB4 in esophageal squamous cell carcinoma (ESCC) cells.
- miRNA-140-5p demonstrates potential as a molecular target for treating ErbB4-overexpressing esophageal cancer.
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

